Depression Clinical Trials in New York, NY

Depression Clinical Trials in New York, NY

View the best 10 depression medical studies in New York, New York. Access promising new therapies by applying to a New York-based Depression clinical trial.

Trials in New York, New York

Here are the top 10 medical studies for depression in New York, New York

Image of Sante Cannabis in Montréal, Canada.

IGC-AD1

Cannabinoid

Recruiting0 awardsPhase 2
This trial tests a natural THC-based medicine called IGC-AD1, given in small doses regularly. It targets people aged 60 and above with Alzheimer's-related dementia who have been experiencing agitation. The THC in the medicine helps reduce agitation by interacting with brain signals. The most recent trial reported significant improvement in agitation using nabilone.
Image of Advanced Research Center /ID# 227073 in Anaheim, United States.

Placebo +1 More

Pharmacotherapy

Recruiting1 awardPhase 3
This trial is testing the safety and effectiveness of Cariprazine for treating depressive episodes in children and teenagers with bipolar I disorder. The goal is to find out if Cariprazine can help young people with this condition. Cariprazine is an atypical antipsychotic recently approved for the treatment of depressive episodes in adults with bipolar I disorder.
Image of Reunion Investigational Site in Decatur, United States.

RE104 for Injection

Procedure

Recruiting1 awardPhase 2
This trial is testing whether a single injection of RE104 can help reduce depression in women who have moderate-to-severe postpartum depression. The goal is to see if this treatment works effectively. The exact way RE104 works isn't detailed, but it likely helps by affecting brain chemicals related to mood.
Image of Duke University in Durham, United States.

Quit on the Go App

Behavioural Intervention

Recruiting1 award
This trial will test a new smartphone app called Quit on the Go, designed to help people with serious mental illness quit smoking. The study will compare this app to traditional methods, with both groups also using nicotine patches and gum. The goal is to see if the app helps more people quit smoking and if it is cost-effective.
Image of Henry Ford Hospital in Detroit, United States.

Health Education Materials +1 More

Behavioral Intervention

Recruiting1 award26 criteria
This trial is studying a physical activity program given together with health education materials to see how well it works compared with giving health education materials alone for patients who have undergone treatment for high-risk stage II or stage III colon cancer.
Image of Psych Research in Toronto, Canada.

Psilocybin

Psychedelic

Recruiting0 awardsPhase 2
This trial tests if very small doses of psilocybin can safely and effectively improve mood in people with major depression who don't respond to or don't want standard treatments. Psilocybin may help by affecting brain chemicals related to mood. Psilocybin has shown promise as a treatment for major depressive disorder and was designated as a breakthrough therapy by the FDA in 2019.
Image of NorthShore University Health System in Evanston, United States.

Brief Behavioral Activation Treatment

Behavioral Intervention

Recruiting1 award1 criteria
This trial is examining whether a brief behavioral activation treatment delivered via telemedicine is as effective as the same treatment delivered in person, and whether the treatment delivered by non-mental health nurses is as effective as when delivered by specialist providers.
Image of St. Michael's Hospital in Toronto, Canada.

Music-based cognitive training

Behavioural Intervention

Recruiting1 award
This trial will test 8 weeks of music-based cognitive training to improve cognitive function in adults with major depressive disorder.
Image of McMaster University in Hamilton, Canada.

Cognitive Behavioral Therapy for Postpartum Depression (PPD)

Recruiting1 award1 criteria
"This trial aims to investigate if an online 9-week group therapy led by public health nurses and individuals who have recovered from postpartum depression is more effective in treating postpartum depression when added to
Image of University of Calgary in Calgary, Canada.

Escitalopram +1 More

Selective Serotonin Reuptake Inhibitor

Recruiting3 awardsPhase 4
This trial will test a predictive biomarker algorithm to help predict treatment outcome for patients with major depressive episodes. The algorithm uses data from previous studies on clinical features, imaging, EEG, and molecular information.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.